ALK and anaplastic large cell lymphoma: Importantly, they found that autophagy inhibitors (i.e., chloroquine) can effectively enhance crizotinib-induced anti-tumoral action in ALK + ALCL cells, and that the combination of autophagy inhibitors and tyrosine kinase inhibitors may improve the therapeutic efficacy for these patients.